rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kathryn W. Kyle

EVP, Chief Legal Officer

Company insider

Files Form 4 as: EVP, Chief Legal Officer, Labcorp Holdings.

In numbers

Trades disclosed
36
Buys
0
Sells
2
Bought
$0
Sold
$455K
Companies
1
Companies where not an officer
0
First trade
6 Feb 2026
Last trade
2 Jul 2026
Last filed
6 Jul 2026

Companies traded

Where they are an officer
LH Labcorp HoldingsOfficer · Diagnostics & Labs · last 2 Jul 20260 buys · 2 sells

Activity over time

1 Jun – 1 Oct
20Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Jul 2026filed 6 Jul 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Sold$26K92 at $286.19filing
2 Jul 2026filed 6 Jul 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Sold$26K92 at $286.19filing
1 Jul 2026filed 6 Jul 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—256filing
1 Jul 2026filed 6 Jul 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$21K73 at $283.88filing
1 Jul 2026filed 6 Jul 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—256 at $0.00filing
1 Jul 2026filed 6 Jul 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—256 at $0.00filing
1 Jul 2026filed 6 Jul 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—256filing
1 Jul 2026filed 6 Jul 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$21K73 at $283.88filing
8 Jun 2026filed 10 Jun 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Sold$201K762 at $263.89filing
8 Jun 2026filed 10 Jun 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Sold$201K762 at $263.89filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code A—1,584 at $0.00filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$121K451 at $268.38filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code A—1,584 at $0.00filing
26 Mar 2026filed 30 Mar 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$121K451 at $268.38filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—216filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$18K62 at $289.89filing
11 Feb 2026filed 13 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—216 at $0.00filing
11 Feb 2026filed 13 Feb 2026LH Labcorp Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—216 at $0.00filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code M—216filing
11 Feb 2026filed 13 Feb 2026LH Labcorp HoldingsDiagnostics & LabsSEC FORM 4 Code F$18K62 at $289.89filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Bryan T. VaughnEVP and President, Diagnostics · EVP and President, Diagnostics at Labcorp Holdings, filing Form 4 there in the last year
Brian J. CaveneyEVP, Pres of BLS, CMO & CSO · EVP, Pres of BLS, CMO & CSO at Labcorp Holdings, filing Form 4 there in the last year
Jonathan C. MeltzerEVP, COO · EVP, COO at Labcorp Holdings, filing Form 4 there in the last year
Akinbolade OyegunwaEVP, CIO & CTO · EVP, CIO & CTO at Labcorp Holdings, filing Form 4 there in the last year
Kerrii B. AndersonDirector · Director at Labcorp Holdings, filing Form 4 there in the last year
April McClain DelaneyRepresentative, MD-06 · Also traded LH in the last 90 days
Adam H. SchechterDirector · Also traded LH in the last 90 days
Amy B. SummyEVP, Chief Marketing Officer · Also traded LH in the last 90 days